{"nctId":"NCT00143507","briefTitle":"The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction","startDateStruct":{"date":"2004-12"},"conditions":["Coronary Disease","Ventricular Dysfunction, Left"],"count":10917,"armGroups":[{"label":"Ivabradine","type":"EXPERIMENTAL","interventionNames":["Drug: Ivabradine"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Ivabradine","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Coronary artery disease\n* Left ventricular systolic dysfunction\n* Sinus rhythm: heart rate (HR) \\>= 60 beats per minute (bpm)\n\nExclusion Criteria:\n\n* Unstable cardiovascular condition\n* Severe congestive heart failure","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Primary Composite Endpoint","description":"First event among cardiovascular death, hospitalisation for acute myocardial infarction (fatal or not), or hospitalisation for new onset or worsening heart failure (fatal or not).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"844","spread":null},{"groupId":"OG001","value":"832","spread":null}]}]}]},{"type":"SECONDARY","title":"Cardiovascular Death","description":"Cardiovascular death including sudden death of unknown cause","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"469","spread":null},{"groupId":"OG001","value":"435","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospitalisation for Acute Myocardial Infarction","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"199","spread":null},{"groupId":"OG001","value":"226","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospitalisation for New Onset or Worsening Heart Failure","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"426","spread":null},{"groupId":"OG001","value":"427","spread":null}]}]}]},{"type":"SECONDARY","title":"All-cause of Mortality","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"572","spread":null},{"groupId":"OG001","value":"547","spread":null}]}]}]},{"type":"SECONDARY","title":"Coronary Artery Disease Death","description":"Death due to heart failure, acute myocardial infarction or cardiac procedure","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"151","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospitalisation for Coronary Revascularisation","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"155","spread":null},{"groupId":"OG001","value":"186","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospitalisation for Unstable Angina","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"114","spread":null},{"groupId":"OG001","value":"105","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospitalisation for Acute Coronary Syndrome (Unstable Angina or Acute Myocardial Infarction)","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"303","spread":null},{"groupId":"OG001","value":"317","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospitalisation for Acute Coronary Syndrome, or Coronary Revascularisation","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"364","spread":null},{"groupId":"OG001","value":"401","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospitalisation for Acute Coronary Syndrome, New Onset or Worsening Heart Failure or Coronary Revascularisation","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"681","spread":null},{"groupId":"OG001","value":"704","spread":null}]}]}]},{"type":"SECONDARY","title":"Cardiovascular Death, or Hospitalisation for New Onset or Worsening Heart Failure","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"757","spread":null},{"groupId":"OG001","value":"723","spread":null}]}]}]},{"type":"SECONDARY","title":"Cardiovascular Death, or Hospitalisation for Acute Myocardial Infarction","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"606","spread":null},{"groupId":"OG001","value":"593","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1625,"n":5477},"commonTop":["Cardiac failure","Blood pressure inadequately controlled","Diabetes mellitus inadequate control","Atrial fibrillation","Phosphenes"]}}}